What is the potential of epigenetics in drug development? - Wikidata - wikimedia - TriplyDB

What is the potential of epigenetics in drug development?

What is the potential of epigenetics in drug development?

http://www.wikidata.org/entity/Q48539090

about

NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds Role of Epigenetics in Biology and Human Diseases.The rise of epigenetic drug discovery.

P2860

Q36033498-C9FC7FF5-1F39-4C71-9AF6-246EDC7C0C46 Q37358791-63443226-0644-49E5-BBE5-52F603DE0188 Q38823638-842B149D-7985-43A9-A146-BCF33FF7BF7B

P2860

What is the potential of epigenetics in drug development?

http://www.wikidata.org/entity/Q48539090

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

What is the potential of epigenetics in drug development?

@en

What is the potential of epigenetics in drug development?

@nl

type

label

What is the potential of epigenetics in drug development?

@en

What is the potential of epigenetics in drug development?

@nl

prefLabel

What is the potential of epigenetics in drug development?

@en

What is the potential of epigenetics in drug development?

@nl

P1433

Q48539090-E60522D0-9797-42B9-95F8-C09E4EB40E82

P1476

Q48539090-840B45B6-03AF-48D4-840C-4B14966E171D

P2093

Q48539090-622FAD57-78E8-4544-90BA-DB190B19DD98

P2860

Q48539090-16B22DAE-95D2-4C37-B36F-CA4312E82289

Q48539090-1DBD3ED6-A6BD-483E-BD95-D3B515CE0DAE

Q48539090-49608182-4120-4966-96CF-E1DB32EAA8DE

Q48539090-6BD13AF9-1913-4FB7-95C5-0DCE0FF25EB5

Q48539090-76EA6CF5-2F0D-4D76-B0BF-F7244016428C

Q48539090-7C6590F6-D2E7-46FE-9F1C-EF6E07AC6C22

Q48539090-875CEE7C-E4AC-4551-840C-21142A128076

Q48539090-AD27E8D9-A6DB-4043-B0C2-B428CDCDB8CD

Q48539090-BA509045-214F-493F-817A-30BD8AC9C2EE

Q48539090-C2E3F341-967E-4308-9BD1-501978D76DD1

P304

Q48539090-F3D79DCD-995D-41FD-B719-425A58355D8A

P31

Q48539090-2389A43F-1C01-415C-88E1-99711E14B14C

Q48539090-de4a8f8d-fec0-4b3a-b26a-c0a790dee44b

P356

Q48539090-1CB83D2E-2EA3-4ABB-B665-47B34B6BB790

P433

Q48539090-09706010-B37C-4498-96F5-A874716AB32B

P478

Q48539090-8D2258E2-3D82-4DD8-AB8A-20CB108FE48C

P577

Q48539090-4837AC21-F476-43DC-827E-16CA3F5F7B39

P698

Q48539090-942526B0-0092-4B9F-8885-EFD664C2A954

P356

P1433

Future Medicinal Chemistry

P1476

What is the potential of epigenetics in drug development?

@en

P2093

Kenneth Lundstrom

http://www.w3.org/2001/XMLSchema#string

P2860

Trials with 'epigenetic' drugs: an update

The epigenomics of cancer

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets.

Decitabine for acute myeloid leukemia.

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.

Circulating miRNAs in cancer: from detection to therapy.

Sequence-based design of bioactive small molecules that target precursor microRNAs.

Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

P304

239-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.15.2

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25826357

http://www.w3.org/2001/XMLSchema#string